A call to action for more aggressive treatment of hypertension

Journal of Hypertension, Supplement

Volumn 17, Issue 1, 1999, Pages

  Lenfant, Claude ^a   Roccella, Edward J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Elderly; Heart disease; Hypertension; Renal disease; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HEALTH EDUCATION; HEALTH PRACTITIONER; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MALE; MEDICARE; META ANALYSIS; PATIENT EDUCATION; PRIORITY JOURNAL; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; PATIENT EDUCATION; PREVALENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 0032973616     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Cupples LA, D'Agostino RB. An epidemiological investigation of cardiovascular disease. Some risk factors related to the annual incidence of cardiovascular disease and death using pool of repeated biennial measurements: 30-year follow up [Framingham Study Monograph Section 34]. In: Kannel WB, Wolf PA, Garrison RJ (editors): NIH Publication No. 87-2703. Springfield, VA: US Department of Commerce, National Technical Information Service; 1987.
2. National Heart, Lung, and Blood Institute. Total mortality and mortality from heart disease, cancer, and stroke from 1950 to 1987 in 27 countries: highlights of trends and their relationships among cause of death. NIH Publication No. 92-3088. Bethesda, MD: US Department of Health and Human Services, National Heart, Lung, and Blood Institute; 1992.
3. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
4. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
5. Stamler J. Blood pressure and high blood pressure. Aspects of risk. Hypertension 1991; 18 (suppl 3):195-1107.
6. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121:951-957.
7. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971; 285:1441-1446.
8. Dawber TR. The Framingham Study: the epidemiology of atherosclerotic disease. Cambridge, MA: Harvard University Press; 1980.
9. Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, Helmy S, Sharaf Y, et al. Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). Hypertension 1995; 26:886-890.
10. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
11. Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics. Healthy People 2000. Review 1995-96. DHHS Publication No. (PHS) 96-1256. Washington, DC: US Department of Health and Human Services; 1996.
12. Subcommittee on Definition and Prevalence, 1984 Joint National Committee. Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension 1985; 7:457-468.
13. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994; 23:275-285.
14. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
15. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277:739-745.
16. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15:967-978.
17. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562.
18. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133:703-712.
19. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153:598-615.
20. Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens 1988; 6 (suppl):S3-S9.
21. US Renal Data System. USRDS 1997 Annual Report. Bethesda, MD: US Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Disease; 1997.
22. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277:1293-1298.
23. National Heart, Lung, and Blood Institute. Fact Book, Fiscal Year 1995. Washington, DC: US Department of Health and Human Services; 1995.
24. Cutler JA, Psaty BM, MacMahon S, Furberg CD. Public health issues in hypertension control: what has been learned from clinical trials. In: Laragh JH, Brenner BM (editors): Hypertension: Pathophysiology, Diagnosis, and Management. 2nd edition. New York: Raven Press; 1995. pp. 253-272.